© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
April 14, 2021
Oncology programs provide the tools needed to improve patient outcomes.
March 26, 2021
NCPA applauded the Michigan’s House passage of the legislation, which would reform many PBM reimbursement practices in the state.
March 25, 2021
In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.
March 18, 2021
Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
March 15, 2021
NCPA lauded the higher reimbursement rate in a statement.
Hospitals employ several strategies for a proactive approach to shortages.
March 12, 2021
Alternative healing approaches and therapies become increasingly popular among consumers.
March 08, 2021
In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.
March 03, 2021
During Women’s History Month, we celebrate the achievements of women in pharmacy practice.
March 01, 2021
Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.
February 25, 2021
Pharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.
February 23, 2021
The approval of the first-line treatment was granted to Regeneron Pharmaceuticals.
February 15, 2021
Despite breakthroughs for personalized medicine, barriers still exist in real-world application.
The presentation discussed the pandemic’s effect on medication safety and provided recommendations to hospitals.
February 05, 2021
What pharmacy needs to know about the transition to the new fee-for-service program in California for Medi-Cal
February 02, 2021
Pharmacy professionals serving minority populations aim to bridge gaps in health care access.
February 01, 2021
Vizient provides drug price estimates for pharmaceutical products used across multiple health system settings.
New branding designed to reflect the company’s mission to drive growth through innovation and consistent pursuit to create healthier futures
January 14, 2021
On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for coronavirus disease 2019 (COVID-19).
January 13, 2021
There are a variety of promising and unique medications in different therapeutic areas expected for approval in 2021.